The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial
Abstract
Background Excess iron has been implicated in cancer risk through increased iron-catalyzed free radical-mediated oxidative stress. Methods A multicenter randomized, controlled, single-blinded clinical trial (VA Cooperative Study #410) tested the hypothesis that reducing iron stores by phlebotomy would influence vascular outcomes in patients with peripheral arterial disease. Patients without a visceral malignancy in the last 5 years (n = 1277) were randomly assigned to control (n = 641) or iron reduction (n = 636). Occurrence of new visceral malignancy and cause-specific mortality data were collected prospectively. Cancer and mortality outcomes in the two arms were compared using intent-to-treat analysis with a Cox proportional hazards regression model. Statistical tests were two-sided. Results Patients were followed up for an average of 4.5 years. Ferritin levels were similar in both groups at baseline but were lower in iron reduction patients than control patients across all 6-month visits (mean = 79.7 ng/mL, 95% confidence interval [CI] = 73.8 to 85.5 ng/mL vs 122.5 ng/mL, 95% CI = 115.5 to 129.5 ng/mL; P Conclusions Iron reduction was associated with lower cancer risk and mortality. Further studies are needed to define the role of body iron in cancer risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, iron removal indeed can reduce the risk of hepatic cancer,16, 17 and presumably of other cancers in humans.18”
From Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats (2018) · cites this paper as [18]
In the citing paper
“Phlebotomy is a relatively safe intervention in humans and has been shown to decrease visceral cancer incidence and mortality in humans.18”
From Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats (2018) · cites this paper as [18]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2095-z · Cited by 172
Research works printed but not linked: 31
- Zacharski, 2000, American heart journal, 140, 98, 10.1067/mhj.2000.106646 · DOI · Paper page
- Toyokuni, 2002, Redox report : communications in free radical research, 7, 189, 10.1179/135100002125000596 · DOI · Paper page
- Gey, 1993, British Medical Bulletin, 49, 679, 10.1093/oxfordjournals.bmb.a072640 · DOI
- Bhasin, 2004, Archives of toxicology, 78, 139, 10.1007/s00204-003-0525-0 · DOI
- Valko, 2006, Chemico-biological interactions, 160, 1, 10.1016/j.cbi.2005.12.009 · DOI · Paper page
- Huang, 2003, Mutation Research, 533, 153, 10.1016/j.mrfmmm.2003.08.023 · DOI
- Selby, 1988, International journal of cancer. Journal international du cancer, 41, 677, 10.1002/ijc.2910410507 · DOI
- ASPEREN, 1995, International Journal of Epidemiology, 24, 665, 10.1093/ije/24.4.665 · DOI
- Wu, 2004, Annals of epidemiology, 14, 195, 10.1016/S1047-2797(03)00119-4 · DOI
- Stevens, 1994, International journal of cancer. Journal international du cancer, 56, 364, 10.1002/ijc.2910560312 · DOI
- Knekt, 1994, International journal of cancer. Journal international du cancer, 56, 379, 10.1002/ijc.2910560315 · DOI
- MERK, 1990, International Journal of Epidemiology, 19, 505, 10.1093/ije/19.3.505 · DOI
- 2008, JNCI Journal of the National Cancer Institute, 100, 572, 10.1093/jnci/djn084 · DOI
- Yeh, 2007, The British journal of surgery, 94, 466, 10.1002/bjs.5488 · DOI
- 2007, JNCI Journal of the National Cancer Institute, 99, 1864, 10.1093/jnci/djm248 · DOI
- 2004, Blood, 104, 2967, 10.1182/blood-2004-05-1866 · DOI
- Hann, 1988, Cancer Research, 48, 4168
- Jiang, 2005, Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 19, 1239, 10.1038/sj.leu.2403734 · DOI
- Zacharski, 2000, American heart journal, 139, 337, 10.1016/S0002-8703(00)90244-8 · DOI
- Zacharski, 2004, American heart journal, 148, 386, 10.1016/j.ahj.2004.03.027 · DOI
- Zacharski, 2007, JAMA, 297, 603, 10.1001/jama.297.6.603 · DOI
- Sullivan, 2007, JAMA, 297, 2075, 10.1001/jama.297.19.2075-a · DOI
- Lakatos, 1986, Controlled clinical trials, 7, 189, 10.1016/0197-2456(86)90047-4 · DOI
- Lakatos, 1988, Biometrics, 44, 229, 10.2307/2531910 · DOI
- O'Brien, 1979, Biometrics, 35, 549, 10.2307/2530245 · DOI · Paper page
- 1993, 88, 400, 10.1080/01621459.1993.10476289 · DOI
- 1958, 53, 457, 10.1080/01621459.1958.10501452 · DOI · Paper page
- 1972, J R STAT SOC SER B, 34, 187, 10.1111/j.2517-6161.1972.tb00899.x · DOI · Paper page
- Yu, 2007, Cell cycle (Georgetown, Tex.), 6, 1982, 10.4161/cc.6.16.4603 · DOI
- Winton, 2005, New England Journal of Medicine, 352, 2589, 10.1056/NEJMoa043623 · DOI
- Auerbach, 2007, Lancet, 369, 1502, 10.1016/S0140-6736(07)60689-8 · DOI
Cited by
Sorted by citations
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Role of iron in carcinogenesis: cancer as a ferrotoxic disease
Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552
Iron availability and infection
Weinberg, E. D. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.07.002 · Cited by 516
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
Bastide, N. M., Pierre, F. H. F., & Corpet, D. E. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0113 · Cited by 397
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
Iron homeostasis in the metabolic syndrome
Datz, C., Felder, T. K., Niederseer, D., & Aigner, E. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12032 · Cited by 181
The neglected significance of “antioxidative stress”
Poljsak, B., & Milisav, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/480895 · Cited by 177
Torti, S. V., & Torti, F. M. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100860 · Cited by 153
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo
Radulescu, S., Brookes, M. J., Salgueiro, P., Ridgway, R. A., McGhee, E., Anderson, K., Ford, S. J., Stones, D. H., Iqbal, T. H., Tselepis, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.003 · Cited by 130
Malignant mesothelioma as an oxidative stress-induced cancer: An update
Chew, S. H., & Toyokuni, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.002 · Cited by 102
Age-dependent and gender-specific changes in mouse tissue iron by strain
Hahn, P., Song, Y., Ying, G.-S., He, X., Beard, J., & Dunaief, J. L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.06.006 · Cited by 98
“Although somewhat controversial, high iron stores may confer increased risk for heart disease (Sullivan, 1989; Salonen et al., 1992) and cancer (Stevens et al., 1988; Zacharski et al., 2008), and hyperferritinemia has been associated with diabetes (Dinneen et al., 1992).”
BackgroundIron and genome stability: an update
Prá, D., Franke, S. I. R., Henriques, J. A. P., & Fenech, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2012.02.001 · Cited by 91
Body iron store as a predictor of oxidative DNA damage in healthy men and women
Hori, A., Mizoue, T., Kasai, H., Kawai, K., Matsushita, Y., Nanri, A., Sato, M., & Ohta, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01394.x · Cited by 72
Chua, A. C. G., Klopcic, B. R. S., Ho, D. S., Fu, S. K., Forrest, C. H., Croft, K. D., Olynyk, J. K., Lawrance, I. C., & Trinder, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078850 · Cited by 76
Oxidative stress as an iceberg in carcinogenesis and cancer biology
Toyokuni, S. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.025 · Cited by 66
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis
Toyokuni, S. (2014) · Redox Report · doi:10.1179/1351000213y.0000000075 · Cited by 56
Nagai, H., Okazaki, Y., Chew, S. H., Misawa, N., Yasui, H., & Toyokuni, S. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0244 · Cited by 39
Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats
Ohara, Y., Chew, S., Shibata, T., Okazaki, Y., Yamashita, K., & Toyokuni, S. (2018) · Cancer Science · doi:10.1111/cas.13460 · Cited by 28
Dietary and Sentinel Factors Leading to Hemochromatosis
Oh, C.-K., & Moon, Y. (2019) · Nutrients · doi:10.3390/nu11051047 · Cited by 12
Alfaro-Magallanes, V., Benito, P., Rael, B., Barba-Moreno, L., Romero-Parra, N., Cupeiro, R., Swinkels, D., Laarakkers, C., Peinado, A., & on behalf of the IronFEMME Study Group (2020) · Nutrients · doi:10.3390/nu12123866 · Cited by 5
Metadata
- Authors
- Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-08
- Volume
- 100
- Issue
- 14
- Pages
- 996-1002
- ISSN
- 0027-8874
- 1460-2105
- Cited by
- 230
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review